- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 03, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,626 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GWIND | ₺29.46 | 4.5% | 109.5% | ₺15.9b | ₺39.79 | PE25.5x | E60.9% | 3.1% | Utilities | ||
GIG | kr33.70 | 2.7% | 19.5% | kr4.4b | kr49.14 | PE27.8x | E40.7% | n/a | Consumer Services | ||
PRL | CA$23.29 | 1.4% | 240.0% | CA$799.9m | CA$24.61 | PE21x | E33.8% | 2.0% | Diversified Financials | ||
ZVRA | US$4.81 | 6.4% | -2.0% | US$198.8m | US$19.00 | PS7.3x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
OSE | €6.20 | 11.5% | 63.4% | €133.7m | €7.15 | PS60x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$21.97 | -6.2% | 29.2% | US$2.4b | US$25.90 | PE22.9x | E44.7% | 3.6% | Energy | ||
WAYS | kr23.50 | 1.3% | -54.8% | kr189.6m | kr39.75 | PS1.7x | E81.8% | 0% | Tech | ||
ELABS | kr15.64 | -2.0% | 42.7% | kr1.6b | kr25.00 | PS24x | E124.6% | n/a | Software | ||
NOHAL | kr23.20 | 5.5% | -8.7% | kr907.3m | kr32.50 | PS8.9x | E56.0% | n/a | Food, Beverage & Tobacco | ||
TGTX | US$16.19 | 20.2% | -52.8% | US$2.4b | US$31.50 | PE56.9x | E46.2% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.76 | 11.2% | 201.3% | US$517.5m | US$11.60 | PS54.4x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €8.47 | 0.5% | 164.7% | €121.0m | €9.70 | PS20x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
MVW | kr8.20 | -6.3% | 5.7% | kr268.3m | kr13.00 | PS24.4x | E66.8% | n/a | Materials | ||
ARES | US$131.91 | -1.3% | 61.0% | US$41.7b | US$146.60 | PE59.4x | E41.7% | 2.8% | Diversified Financials | ||
AGP | €8.32 | 8.9% | 137.7% | €144.0m | €12.75 | PE29.3x | E22.8% | n/a | Capital Goods | ||
NEWBRY | kr3.23 | -5.3% | -42.7% | kr78.4m | kr8.00 | PS3.4x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.75 | 2.7% | -46.5% | US$225.0m | US$25.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.50 | -7.4% | 39.3% | kr407.3m | kr1.80 | PS4.5x | E98.1% | n/a | Tech | ||
CALTX | kr106.60 | 2.8% | -16.8% | kr5.7b | kr208.00 | PS4.7x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$74.80 | 4.3% | 1.4% | US$3.5b | US$122.69 | PS13.1x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$152.33 | 6.3% | -28.2% | US$19.0b | US$221.12 | PS9.6x | E60.5% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €9.65 | 1.6% | 4.9% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
ATAKP | ₺47.18 | -0.8% | n/a | ₺6.5b | ₺67.66 | PE22.1x | E72.8% | n/a | Food, Beverage & Tobacco | ||
FWRY | ج.م5.93 | -2.8% | 2.2% | ج.م20.2b | ج.م7.20 | PE32.7x | E34.8% | n/a | Diversified Financials |